Daniel Lorch
Pulmonary Disease · Brandon, FLNPI 1821033242
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Harmony Biosciences LLC at 37.5% of the total. Reporting peaked in 2020 at $2,876 and has fallen 95.8% since, to $122 in 2024. That places this record below the midpoint for pulmonary disease clinicians in FL, where the typical reported total is $2,936.
Across 35 payments — averaging $113.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$1K
- AstraZeneca$1K
- Jazz Pharmaceuticals Inc.$470
- GSK$222
- Lilly USA, LLC$122
- Bayer$78
- plus $186 from 7 others
Across 658 payments — averaging $8517.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3M
- Modernatx, Inc.$530K
- Alkermes, Inc.$467K
- Eisai Inc.$440K
- Merck$312K
- Jazz Pharmaceuticals Inc.$248K
- plus $631K from 8 others
What the payments were for
- Consulting fees$1,35034%
- Speaking & faculty fees$1,35034%
- Food & beverage$1,26232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 2 | $1,484 |
| AstraZeneca | 4 | $1,400 |
| Jazz Pharmaceuticals Inc. | 8 | $470 |
| GSK | 9 | $222 |
| Lilly USA, LLC | 1 | $122 |
| Bayer | 2 | $78 |
| Insmed, Inc. | 2 | $48 |
| Boehringer Ingelheim | 2 | $33 |
| Philips North America LLC | 1 | $29 |
| Vapotherm Inc | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$1,484
- BEVESPI AEROSPHERE$1,350
- XYREM$255
- ZEPBOUND$122
- NUCALA$110
How this compares
$3,962 in reported general payments places this provider in the 50th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Brandon
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.